E-LIB Suche - Ergebnisse für: Nooka, Ajay

1

Consensus guidelines and recommendations for the management..:

Lin, Yi ; Qiu, Lugui ; Usmani, Saad...
The Lancet Oncology. 25 (2024) 8 - p. e374-e387 , 2024

Link: https://doi.org/10.1016/..

2

Health-related quality of life in patients with triple-clas..:

Delforge, Michel ; Patel, Krina ; Eliason, Laurie...
The Lancet Haematology. 11 (2024) 3 - p. e216-e227 , 2024

Link: https://doi.org/10.1016/..

3

Pembrolizumab and low-dose, single-fraction radiotherapy fo..:

Khan, Mohammad K ; Nasti, Tahseen H ; Qian, Joshua Y...
The Lancet Haematology. 11 (2024) 7 - p. e510-e520 , 2024

Link: https://doi.org/10.1016/..

4

Teclistamab impairs humoral immunity in patients with heavi..:

Frerichs, Kristine A. ; Verkleij, Christie P. M. ; Mateos, Maria Victoria...
Blood Advances. 8 (2023) 1 - p. 194-206 , 2023

Link: https://doi.org/10.1182/..

5

P-165 Incidence, risk factors and impact of supraventricula..:

Simon, Kathryn ; Joseph, Nisha ; Mandawat, Anant...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S126-S127 , 2023

Link: https://doi.org/10.1016/..

6

MM-192 Preliminary Recommendations for Prevention and Manag..:

Manier, Salomon ; Nooka, Ajay ; Rodriguez, Cesar...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S480-S481 , 2023

Link: https://doi.org/10.1016/..

7

Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion ..:

Chung, David J. ; Shah, Nina ; Wu, Juan...
Clinical Cancer Research. 29 (2023) 23 - p. 4784-4796 , 2023

Link: https://doi.org/10.1158/..

8

P-141 Response and survival outcomes of daratumumab, lenali..:

Joseph, Nisha ; Kaufman, Jonathan ; Lonial, Sagar...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S113 , 2023

Link: https://doi.org/10.1016/..

9

Phase 1 Trial of AUC-Targeted Melphalan in Myeloma Patients..:

Sweiss, Karen ; Guo, Janet ; Kim, Kyeongmin...
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S168-S169 , 2023

Link: https://doi.org/10.1016/..

10

P-205 Heme promotes venetoclax resistance in multiple myelo..:

Nair, Remya ; Hong, An Vu ; Freer, Abigail...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S148 , 2023

Link: https://doi.org/10.1016/..

11

P905: PATIENT REPORTED OUTCOMES IN TRIPLE CLASS EXPOSED, RE..:

Delforge, Michel ; Patel, Krina ; Eliason, Laurie...
HemaSphere. 7 (2023) S3 - p. e031009e , 2023

Link: https://doi.org/10.1097/..

12

P1506: TECLISTAMAB REDUCES POLYCLONAL IMMUNOGLOBULIN LEVELS..:

Frerichs, Kristine ; Verkleij, Christie ; Mateos, Maria-Victoria...
HemaSphere. 7 (2023) S3 - p. e5193345 , 2023

Link: https://doi.org/10.1097/..

13

P870: EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH R..:

Manier, Salomon ; Lesokhin, Alexander ; Mohty, Mohamad...
HemaSphere. 7 (2023) S3 - p. e26808c7 , 2023

Link: https://doi.org/10.1097/..

14

P-031 Idecabtagene vicleucel (ide-cel) vs standard regimens..:

Manier, Salomon ; Rodriguez-Otero, Paula ; Mateos, Maria-Victoria...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S50-S51 , 2023

Link: https://doi.org/10.1016/..

15

Detailed overview of incidence and management of cytokine r..:

Martin, Thomas G. ; Mateos, Maria Victoria ; Nooka, Ajay...
Cancer. 129 (2023) 13 - p. 2035-2046 , 2023

Link: https://doi.org/10.1002/..